A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Clinical trial NCT05183646 · RECRUITING
Trial details
- NCT number
- NCT05183646
- Sponsor
- Dimerix Bioscience Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2029-12-01
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.